Clinical analysis of 150 patients with idiopathic pulmonary arterial hypertension

Chinese Journal of Cardiology

Volumn 40, Issue 8, 2012, Pages 657-661

  Dong, Lin ^a   He, Jian Guo ^a   Shan, Guang Liang ^a   Lu, Xian Ling ^a   Zeng, Wei Jie ^a   Liu, Zhi Hong ^a   Zhou, Da Xin ^a   Cao, Hua ^a   Ni, Xin Hai ^a   Wang, Guang Yi ^a   Shen, Jie Yan ^a   Tian, Hong Yan ^a   Sun, Yun Juan ^a   Gu, Qing ^a   Zhao, Zhi Hui ^a   Cheng, Xian Sheng ^a   Xiong, Chang Ming ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Hemodynamic features; Hypertension, pulmonary; Ventricular dysfunction

Indexed keywords

ADULT; ARTICLE; BODY MASS; BORG DYSPNEA SCORE; CLINICAL FEATURE; COHORT ANALYSIS; DYSPNEA; ELECTROCARDIOGRAM; EXERCISE TEST; FATIGUE; FEMALE; FUNCTIONAL STATUS; HEART CATHETERIZATION; HEART HEMODYNAMICS; HEART INDEX; HEART RIGHT ATRIUM PRESSURE; HEART RIGHT VENTRICLE HYPERTROPHY; HOSPITAL PATIENT; HUMAN; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PULMONARY HYPERTENSION; SCORING SYSTEM; SEX RATIO; SIX MINUTES WALKING TEST; WALKING;

ADOLESCENT; ADULT; AGED; FEMALE; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; VENTRICULAR FUNCTION; YOUNG ADULT;

EID: 84867707210     PISSN: 02533758     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0253-3758.2012.08.007     Document Type: Article

References (21)

1. Humbert M, Sitbon O, Chaouat A, et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation, 2010, 122: 156-163.
2. Falcetti E, Hall S M, Phillips P G, et al. Smooth muscle proliferation and role of the prostacyclin (IP) receptor in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med, 2010, 182:1161-1170.
3. Sandoval J, Bauerle O, Gomez A, et al. Primary pulmonary hypertension in children: clinical characterization and survival. J Am Coll Cardiol, 1995, 25:466-474.
4. Wensel R, Opitz C F, Anker S D, et al. Assessment of survival in patients with primary pulmonary hypertension importance of cardiopulmonary exercise testing. Circulation, 2002, 106: 319-324.
5. McLaughlin V V, Archer S L, Badesch D B, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology foundation task force on expert consensus documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol, 2009, 53:1573-1619.
6. Galiè N, Torbicki A, Barst R, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The task force on diagnosis and treatment of pulmonary arterial hypertension of the European Society of Cardilogy. Eur Heart J, 2004, 25: 2243-2278.
7. ATS committee on proficiency standards for clinical pulmonary function laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med, 2002, 166:111-117.
8. D'Alonzo G E, Barst R J, Ayres S M, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med, 1991, 115: 343-349.
9. Rich S, Dantzker D R, Ayres S M, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med, 1987, 107: 216-223.
10. Peacock A J, Murphy N F, McMurray J J, et al. An epidemiological study of pulmonary arterial hypertension. Eur Respir J, 2007, 30: 104-109.
11. Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France results from a national registry. Am J Respir Crit Care Med, 2006, 173:1023-1030.
12. Jing Z C, Xu X Q, Han Z Y, et al. Registry and survival study in Chinese patients with idiopathic and familial pulmonary arterial hypertension. Chest, 2007, 132:373-379.
13. Henappan T, Shah S J, Rich S, et al. A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Respir J, 2007, 30: 1103-1110.
14. Badesch D B, Raskob G E, Elliott C G, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL registry. Chest, 2010, 137:376-387.
15. Rich S, Dantzker R, Ayres S, et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med, 1987, 107: 216-223.
16. Burger C D, Foreman A J, Miller D P, et al. Comparision of body habitus in patients with pulmonary arterial hypertension enrolled in the registry to evaluate early and long-term PAH Disease management with normative values from the national health and nutrition examination survey. Mayo Clin Proc, 2011, 86:105-112.
17. Zheng W, McLerran D F, Rolland B, et al. Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med, 2011, 364:719-729.
18. Miyamoto S, Nagaya N, Satoh T, et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med, 2000, 161(2 Pt 1): 487-492.
19. Diller G P, Dimopoulos K, Okonko D, et al. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation, 2005, 112:828-835.
20. Wensel R, Opitz C F, Anker S D, et al. Assessment of survival in patients with primary pulmonary hypertension; importance of cardiopulmonary exercise testing. Circulation, 2002, 106: 319-324.
21. Degano B, Sitbon O, Savale L, et al. Characterization of pulmonary arterial hypertension patients walking more than 450 m in 6 min at diagnosis. Chest, 2010, 137:1297-1303.